Methylmalonic Acid

Your standard vitamin B12 blood test can miss deficiency entirely. Many people walk around with normal serum B12 but a body that is not actually using it, which shows up as nerve symptoms, fatigue, balance problems, and cognitive slowing that get blamed on aging. Urinary MMA (methylmalonic acid) catches this gap by measuring whether the B12-dependent machinery in your cells is doing its job.

When B12 is working properly, the precursor to MMA gets converted into a usable fuel molecule and MMA never accumulates. When the system stalls, MMA spills into the urine. This is why a high urinary MMA result tells you something a standard B12 level cannot: how your cells are actually functioning, not just how much B12 is floating in your blood.

What This Test Actually Reflects

When your body breaks down certain amino acids, odd-chain fats, and a compound called propionate inside the energy-producing compartments of your cells (the mitochondria), it produces a molecule called methylmalonyl-CoA. A B12-dependent enzyme called methylmalonyl-CoA mutase is supposed to convert methylmalonyl-CoA into succinyl-CoA, a fuel intermediate. When B12 is low or that enzyme is genetically impaired, methylmalonyl-CoA backs up and is broken down into MMA, which then spills into the urine.

Urinary MMA is typically reported as a ratio against creatinine, a waste product that gives a reference for how concentrated your urine sample is. This adjustment is important because urine concentration changes throughout the day depending on hydration. A 24-hour urine collection can give an even better picture of total MMA output but is harder to do in real life.

Vitamin B12 Deficiency

This is the main reason to test. In a classic prospective evaluation using gas chromatography-mass spectrometry (a precise lab method for measuring small molecules), urinary MMA caught essentially all people with clinically confirmed B12 deficiency (100% sensitivity, 7 of 7 deficient patients) and correctly cleared the large majority of people without it (99% specificity, 88 of 89 non-deficient). In a more recent hospital study of patients with borderline B12 levels, the urinary MMA/creatinine ratio had specificity of around 88% at a threshold of 1.45 µmol/mmol, meaning it was very good at confirming deficiency but missed some milder cases.

A key advantage of the urine test over the blood version is that the urinary ratio is much less affected by mild to moderate kidney impairment. Plasma MMA rises when kidney function drops, which can falsely suggest B12 deficiency. The urinary MMA/creatinine ratio was independent of renal function in a study of patients with mild-to-moderate kidney impairment, which makes it especially useful in older adults and anyone with reduced kidney function. Severe kidney disease still complicates interpretation.

In a pilot study of adults aged 70 and older, high-dose oral B12 lowered the urinary MMA/creatinine ratio, and the people whose ratios fell the most also had better cognitive outcomes. Like several established treatment-monitoring biomarkers, this one moves in response to the right treatment, giving you a feedback loop on whether intervention is working.

How It Compares to Standard B12 Testing

Sources: Supakul et al. 2020; Matchar et al. 1987; Lee et al. 2019.

What this means for you: if your standard B12 came back in the normal range but you have symptoms that fit B12 deficiency (numbness, tingling, balance issues, fatigue, brain fog, mood changes), urinary MMA can tell you whether your cells are actually getting the B12 they need. A normal serum B12 does not rule out functional deficiency, and expert consensus now recommends combining at least two biomarkers for a reliable answer.

Inherited Methylmalonic Acidemia

A small group of people are born with genetic defects in the MMUT gene (formerly called MUT) or related cobalamin pathway genes that cause MMA to accumulate at very high levels, sometimes thousands of times normal. This is called methylmalonic acidemia. Urinary MMA is used to diagnose these conditions and to monitor disease severity over time. In one long-term outcome study, higher urinary MMA excretion in affected patients predicted development of chronic kidney failure, specifically in the mut0 and cblB subtypes. This is rare and usually identified in infancy through newborn screening, but late-onset cases do exist.

Mitochondrial Health and Longevity

Beyond B12, MMA is being studied as a marker of overall mitochondrial function. The mitochondria are the parts of your cells that produce energy, and they tend to work less efficiently as you age. Most of this research has measured MMA in blood rather than urine, but the underlying biology is the same pathway, so the findings are relevant context for what your urinary number might be signaling.

In a study of about 23,000 adults from the U.S. general population, higher blood MMA was linked to higher all-cause and cardiovascular death rates over follow-up. In another analysis of more than 13,000 adults, higher blood MMA tracked with accelerated phenotypic aging (a composite measure of how old your body looks biologically compared to your actual age), independent of B12 and creatinine. These associations suggest MMA captures something about cellular wear and tear that B12 alone does not.

These findings come from blood MMA, not urinary MMA specifically. Whether urinary MMA tracks the same mitochondrial signal as closely has not been studied at the same scale. The most defensible interpretation: a persistently high urinary MMA without a clear B12 explanation deserves further investigation rather than dismissal.

Kidney Function and Cardiovascular Risk

In a cross-sectional analysis of NHANES data, higher serum MMA levels were positively associated with chronic kidney disease risk. Among adults with existing chronic kidney disease, higher circulating MMA also predicted higher all-cause and cardiovascular mortality, while serum B12 itself did not. Again, these data are from blood rather than urine, but they reinforce that MMA is not just a B12 readout. It reflects a broader metabolic strain that has real downstream consequences.

Why One Reading Is Not Enough

Urinary MMA varies with what you ate, how hydrated you are, your kidney function, and where you are in your day. A single elevated reading is a signal to look closer, not a final answer. The most informative use of this test is serial: get a baseline, retest in 3 to 6 months if you are starting B12 therapy or making dietary changes, and at least annually if you are tracking long-term metabolic health.

When urinary MMA drops in response to B12 supplementation, it confirms two things at once: that your previous elevation was actually due to functional B12 deficiency, and that the treatment is working. This treatment-response loop makes it especially useful for monitoring whether your intervention is actually fixing the underlying problem.

When Results Can Be Misleading

• Kidney impairment: severe kidney failure reduces MMA clearance, which can raise urinary values regardless of B12 status. The MMA/creatinine ratio adjusts for this to some degree, but advanced kidney disease still complicates interpretation.
• Nitrous oxide exposure: recreational use of nitrous oxide (laughing gas) inactivates B12-dependent enzymes and raises urinary MMA within days. The lab number reflects real cellular damage, not just a transient artifact.
• Thyroid disease: MMA may be falsely elevated in thyroid disease, so untreated or poorly controlled thyroid conditions should be considered when interpreting an unexpected result.
• Maternal B12 status in newborn screening: maternal B12 deficiency during pregnancy can elevate MMA in newborns. This reflects true acquired B12 deficiency rather than an inherited disease, but the distinction matters for follow-up.
• Folic acid supplementation: in a randomized trial of folate supplementation in people with low-marginal B12, folic acid did not change plasma MMA levels. However, observational data suggest that in people who are already B12-deficient, high folate may be associated with higher MMA and homocysteine, so the relationship is not as simple as 'folate has no effect.'

What to Do With an Unexpected Result

If your urinary MMA comes back elevated, the next step is not to panic but to pattern-match. Order or retrieve a serum B12, plasma homocysteine, holotranscobalamin (the active fraction of B12, a more sensitive first-line marker of B12 status than total serum B12), and a basic kidney function panel (creatinine, eGFR). The combination tells the story. High MMA with high homocysteine and low or low-normal B12 (or low holotranscobalamin) points squarely at functional B12 deficiency, which is treatable. High MMA with isolated kidney dysfunction suggests the elevation may be partly clearance-related. Very high MMA with no clear B12 or kidney explanation, especially with neurological symptoms, warrants involvement of a metabolic specialist or hematologist to rule out rarer conditions.

If a low result reassures you but symptoms persist, do not stop investigating. Urinary MMA is specific but not perfectly sensitive, especially at higher cutoffs. Pair it with serum B12, holotranscobalamin, and homocysteine for a fuller picture, and consider repeat testing after a few months of consistent diet.